US COVID-19 Update

March 09 2020

Like so many, NRG Oncology leadership is tracking closely with developments related to the spread of the COVID-19, or Coronavirus. Many of our Member Institutions have enacted travel bans and other initiatives aimed at reducing the risk of exposure. In line with the current recommendations, NRG Oncology has ceased any international travel – an activity impacting our Audit Program, and continues to assess the ever changing status and recommendations. We are respecting our Member Site’s current restrictions and ensuring we are doing all we can support the continuing good health and wellness of our staff and others working on our behalf. We welcome related updates from our Members, and can address any queries through our Executive Director, Kati Stoermer ( stoermerk@nrgoncology.org or 412-697-6640) If you have questions specific to an upcoming Audit, please contact the Mimi Passarello ( passarellom@nrgoncology.org or 412-383-2189.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.